Literature DB >> 25641201

Hemoglobin, alkalic phosphatase, and C-reactive protein predict the outcome in patients with liposarcoma.

Joannis Panotopoulos1, Florian Posch, Benjamin Alici, Philipp Funovics, Christoph Stihsen, Gabriele Amann, Thomas Brodowicz, Reinhard Windhager, Cihan Ay.   

Abstract

Data on prognostic biomarkers in soft tissue sarcomas are scarce. The aim of the study was to define prognostic markers in patients with a liposarcoma, a subtype of sarcoma derived from adipose tissue. We restrospectively reviewed 85 patients with liposarcoma treated at our department from May 1994 to October 2011. Kaplan-Meier curves, uni-, and multivariable Cox proportional hazard models and competing risk analysis were performed to evaluate the association between putative biomarkers with disease-specific and overall survival. We observed a significant association between both alkalic phosphatase (ALP; subhazard ratio [SHR] per 1 unit increase: 1.35; 95%CI 1.10-1.65; p = 0.005) and C-reactive protein (CRP; SHR per 1 mg/dl increase: 2,57; 95%CI 1.36-4,86; p = 0.004) with disease-specific survival. Hemoglobin (Hb) (HR per 1 g/dl increase: 065; 95%CI 0.48-0.87; p = 0.003) was associated with overall survival. These associations prevailed after multivariable adjustment for AJCC tumor stage. This study identifies CRP and ALP as novel independent predictors of disease-specific survival in patients with liposarcoma.
© 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  CRP; alkalic phospahtase; hemoglobin; liposarcoma; prognosis

Mesh:

Substances:

Year:  2015        PMID: 25641201     DOI: 10.1002/jor.22827

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  9 in total

Review 1.  Liposarcoma: molecular targets and therapeutic implications.

Authors:  Kate Lynn J Bill; Lucia Casadei; Bethany C Prudner; Hans Iwenofu; Anne M Strohecker; Raphael E Pollock
Journal:  Cell Mol Life Sci       Date:  2016-05-12       Impact factor: 9.261

2.  C-reactive protein and tumour diagnosis predict survival in patients treated surgically for long bone metastases.

Authors:  Costantino Errani; Monica Cosentino; Giovanni Ciani; Lorenzo Ferra; Patricio A Alfaro; Barbara Bordini; Davide M Donati
Journal:  Int Orthop       Date:  2021-01-04       Impact factor: 3.075

3.  C-reactive protein: An independent predictor for dedifferentiated chondrosarcoma.

Authors:  Elena Nemecek; Philipp Theodor Funovics; Gerhard Martin Hobusch; Susanna Lang; Madeleine Willegger; Florian Sevelda; Thomas Brodowicz; Christoph Stihsen; Reinhard Windhager; Joannis Panotopoulos
Journal:  J Orthop Res       Date:  2018-05-24       Impact factor: 3.494

4.  Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.

Authors:  Florian Moik; Jakob M Riedl; Thomas Winder; Angelika Terbuch; Christopher H Rossmann; Joanna Szkandera; Thomas Bauernhofer; Anne-Katrin Kasparek; Renate Schaberl-Moser; Andreas Reicher; Felix Prinz; Martin Pichler; Herbert Stöger; Michael Stotz; Armin Gerger; Florian Posch
Journal:  Sci Rep       Date:  2019-04-03       Impact factor: 4.379

5.  The value of C-reactive protein as an independent prognostic indicator for disease-specific survival in patients with soft tissue sarcoma: A meta-analysis.

Authors:  Xiaolin Wang; Song Liu; Xiaoli Zhao; Erhu Fang; Xiang Zhao
Journal:  PLoS One       Date:  2019-07-01       Impact factor: 3.240

6.  Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer.

Authors:  Florian Posch; Karina Silina; Sebastian Leibl; Axel Mündlein; Holger Moch; Alexander Siebenhüner; Panagiotis Samaras; Jakob Riedl; Michael Stotz; Joanna Szkandera; Herbert Stöger; Martin Pichler; Roger Stupp; Maries van den Broek; Peter Schraml; Armin Gerger; Ulf Petrausch; Thomas Winder
Journal:  Oncoimmunology       Date:  2017-12-18       Impact factor: 8.110

7.  The diagnostic and prognostic value of interleukin-6 in patients with soft tissue sarcomas.

Authors:  Tomohito Hagi; Tomoki Nakamura; Takahiro Iino; Takao Matsubara; Kunihiro Asanuma; Akihiko Matsumine; Akihiro Sudo
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

8.  Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort Study.

Authors:  Florian Posch; Richard Partl; Carmen Döller; Jakob M Riedl; Maria Smolle; Lukas Leitner; Marko Bergovec; Bernadette Liegl-Atzwanger; Michael Stotz; Angelika Bezan; Armin Gerger; Martin Pichler; Karin S Kapp; Herbert Stöger; Andreas Leithner; Joanna Szkandera
Journal:  Ann Surg Oncol       Date:  2017-09-11       Impact factor: 5.344

9.  Meta-Analysis of Hematological Biomarkers as Reliable Indicators of Soft Tissue Sarcoma Prognosis.

Authors:  Long-Qing Li; Zhen-Hua Bai; Liang-Hao Zhang; Yan Zhang; Xin-Chang Lu; Yi Zhang; Yong-Kui Liu; Jia Wen; Jia-Zhen Li
Journal:  Front Oncol       Date:  2020-01-30       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.